Agency Forms Undergoing Paperwork Reduction Act Review, 60199-60200 [2017-27257]

Download as PDF 60199 Federal Register / Vol. 82, No. 242 / Tuesday, December 19, 2017 / Notices Assisted Living, American Seniors Housing Association, Argentum (formerly Assisted Living Federation of America), National Adult Day Services Association; universities; foundations; and other private sector organizations such as the Alzheimer’s Association and the AARP Public Policy Institute. Expected burden from data collection for eligible cases is 80 minutes per respondent: 5 minutes for a contact confirmation call; 15 minutes for a screener and appointment setting call; 30 minutes for a provider questionnaire; and 30 minutes for a sampling and services user questionnaire. We estimate an eligibility rate for ADSCs of 86% and for RCCs of 76%. One-year clearance requested to cover the collection of data. The burden for the collection shown in Table 1 below. There is no cost to respondents other than their time to participate. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Type of respondents Form name RCC/ADSC Director/Designated Staff Member. RCC/ADSC Director/Designated Staff Member. RCC Director/Designated Staff Member. ADSC Director/Designated Staff Member. RCC Director/Designated Staff Member. ADSC Director/Designated Staff Member. Contact Confirmation Call ................ 3,740 1 5/60 312 Screener and Appointment Setting Call. RCC Provider Questionnaire ........... 3,740 1 15/60 935 1,589 1 30/60 795 ADSC Provider Questionnaire ......... 1,419 1 30/60 710 RCC Sampling and Services User Questionnaire. ADSC Sampling and Services User Questionnaire. 1,589 1 30/60 795 1,419 1 30/60 710 Total ........................................... ........................................................... ........................ ........................ ........................ 4,257 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–27258 Filed 12–18–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–18–17AMP] sradovich on DSK3GMQ082PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Evaluation of the SAMHSA Naloxone Education and Distribution Program to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on July 17, 2017 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. VerDate Sep<11>2014 17:47 Dec 18, 2017 Jkt 244001 CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Evaluation of the SAMHSA Naloxone Education and Distribution Program— New—National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Background and Brief Description Overdose deaths involving prescription opioids and heroin have reached epidemic levels in the U.S. and continue to rise. To address the prescription drug/opioid overdose crisis, the federal government has recently allocated funding to improve access to treatment for opioid use disorders, reduce opioid related deaths, and strengthen prevention efforts. One program resulting from the federal government’s efforts to address the opioid crisis is the Substance Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/Opioid OverdoseRelated Deaths. This proposed information collection project will help evaluate this program. Through this program, SAMHSA awarded funding to 12 states. The funding is aimed at reducing the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years of E:\FR\FM\19DEN1.SGM 19DEN1 60200 Federal Register / Vol. 82, No. 242 / Tuesday, December 19, 2017 / Notices age and older through educating and training first responders and other key community sectors on the prevention of prescription drug/opioid overdoserelated deaths, including the purchase and distribution of naloxone. SAMHSA is funding the grant and CDC is responsible for conducting the grantee evaluation. The intended use of the resulting data is to increase CDC and SAMHSA understanding of the scope and impact of the program on overdose fatalities responders, social service providers, laypersons including end users and their family and friend. All focus groups and interviews will be analyzed through qualitative content analysis, including utilization of a systematic coding scheme. Total burden in hours for this collection is 381. There are no costs to respondents other than their time. CDC requests a three-year OMB approval to collect the necessary project-related information. and how program effectiveness may vary among different sub-populations and settings, and to increase knowledge of barriers and facilitators to program implementation. Researchers will use key informant interviews and focus groups with participants in the activities enacted by the twelve state grant recipients. Participants will include state administrators of the grant and other PDO/Naloxone stakeholders including advisory council members, first ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Type of respondents Form name PDO/Naloxone Advisory Committee Members and Grantees. PDO/Naloxone Grantees ................................ PDO/Naloxone Stakeholders and Partners .... PDO/Naloxone Laypersons ............................ Focus Group Discussion Guide ..................... 140 1 1.5 Key Informant Interview Guide for Grantees Key Informant Interview Guide for Partners .. Key Informant Interview Guide for Laypersons. Recruitment contact script ............................. 36 84 24 1 1 1 1 1 1 284 1 5/60 Key Informant Selection Tool ......................... 12 1 15/60 All participants (PDO Naloxone grantees, advisory committee, stakeholders and partners, laypersons). PDO/Naloxone Grantees ................................ Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–27257 Filed 12–18–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Comment Request Proposed Projects Title: ACF Generic Clearance for Mandatory Grant Financial Reports. OMB No.: 0970—New. Description: OMB has granted permission for ACF to submit a request for a generic clearance to be used for the financial reports used in the administration of mandatory grants. This clearance supports the Departments initiative of Generating Efficiencies through Streamlined Processes by employing an abbreviated process. If approved program offices will be at liberty to tailor a financial report to their specific needs rather than adhering to a standard form. Respondents: States and Territories. ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Mandatory Grant Financial Reports ................................................................. sradovich on DSK3GMQ082PROD with NOTICES Instrument 900 4 5 18,000 Estimated Total Annual Burden Hours: In compliance with the requirements of the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. Chap. 35), the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and VerDate Sep<11>2014 17:47 Dec 18, 2017 Jkt 244001 Families, Office of Planning, Research and Evaluation, 330 C Street SW, Washington, DC 20201. Attn: ACF Reports Clearance Officer. Email address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to E:\FR\FM\19DEN1.SGM 19DEN1

Agencies

[Federal Register Volume 82, Number 242 (Tuesday, December 19, 2017)]
[Notices]
[Pages 60199-60200]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-18-17AMP]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Evaluation of the SAMHSA Naloxone Education 
and Distribution Program to the Office of Management and Budget (OMB) 
for review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
July 17, 2017 to obtain comments from the public and affected agencies. 
CDC did not receive comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Evaluation of the SAMHSA Naloxone Education and Distribution 
Program--New--National Center for Injury Prevention and Control 
(NCIPC), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Overdose deaths involving prescription opioids and heroin have 
reached epidemic levels in the U.S. and continue to rise. To address 
the prescription drug/opioid overdose crisis, the federal government 
has recently allocated funding to improve access to treatment for 
opioid use disorders, reduce opioid related deaths, and strengthen 
prevention efforts. One program resulting from the federal government's 
efforts to address the opioid crisis is the Substance Abuse and Mental 
Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/
Opioid Overdose-Related Deaths. This proposed information collection 
project will help evaluate this program.
    Through this program, SAMHSA awarded funding to 12 states. The 
funding is aimed at reducing the number of prescription drug/opioid 
overdose-related deaths and adverse events among individuals 18 years 
of

[[Page 60200]]

age and older through educating and training first responders and other 
key community sectors on the prevention of prescription drug/opioid 
overdose-related deaths, including the purchase and distribution of 
naloxone. SAMHSA is funding the grant and CDC is responsible for 
conducting the grantee evaluation.
    The intended use of the resulting data is to increase CDC and 
SAMHSA understanding of the scope and impact of the program on overdose 
fatalities and how program effectiveness may vary among different sub-
populations and settings, and to increase knowledge of barriers and 
facilitators to program implementation.
    Researchers will use key informant interviews and focus groups with 
participants in the activities enacted by the twelve state grant 
recipients. Participants will include state administrators of the grant 
and other PDO/Naloxone stakeholders including advisory council members, 
first responders, social service providers, laypersons including end 
users and their family and friend. All focus groups and interviews will 
be analyzed through qualitative content analysis, including utilization 
of a systematic coding scheme.
    Total burden in hours for this collection is 381. There are no 
costs to respondents other than their time. CDC requests a three-year 
OMB approval to collect the necessary project-related information.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
PDO/Naloxone Advisory Committee         Focus Group Discussion               140               1             1.5
 Members and Grantees.                   Guide.
PDO/Naloxone Grantees.................  Key Informant Interview               36               1               1
                                         Guide for Grantees.
PDO/Naloxone Stakeholders and Partners  Key Informant Interview               84               1               1
                                         Guide for Partners.
PDO/Naloxone Laypersons...............  Key Informant Interview               24               1               1
                                         Guide for Laypersons.
All participants (PDO Naloxone          Recruitment contact                  284               1            5/60
 grantees, advisory committee,           script.
 stakeholders and partners,
 laypersons).
PDO/Naloxone Grantees.................  Key Informant Selection               12               1           15/60
                                         Tool.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-27257 Filed 12-18-17; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.